CFTR and cystic fibrosis: Funders have adopted these priorities leading to at least £23 million of UK funding alone.2 Much has changed in CF over the past 5 years, with the CF transmembrane conductance regulator (CFTR) modulator therapy available to many (but not all) people with CF (pwCF).